CRISPR Therapeutics AG Profit Margin 2015-2021 | CRSP
Current and historical gross margin, operating margin and net profit margin for CRISPR Therapeutics AG (CRSP) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. CRISPR Therapeutics AG net profit margin as of September 30, 2021 is 45.64%.
|CRISPR Therapeutics AG Annual Profit Margins
|CRISPR Therapeutics AG Quarterly Profit Margins
||Medical - Biomedical and Genetics
CRISPR Therapeutics AG is a gene-editing company. It focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR Therapeutics AG is headquartered in Basel, Switzerland.